高级检索
任锦丽, 张黎, 王思惟, 张召锋. 燕麦β-葡聚糖对糖尿病大鼠肾病干预作用及机制[J]. 中国公共卫生, 2018, 34(6): 819-822. DOI: 10.11847/zgggws1117131
引用本文: 任锦丽, 张黎, 王思惟, 张召锋. 燕麦β-葡聚糖对糖尿病大鼠肾病干预作用及机制[J]. 中国公共卫生, 2018, 34(6): 819-822. DOI: 10.11847/zgggws1117131
Jin-li REN, Li ZHANG, Si-wei WANG, . Intervention effect and mechanism of oat β-glucan on diabetic nephropathy in rats[J]. Chinese Journal of Public Health, 2018, 34(6): 819-822. DOI: 10.11847/zgggws1117131
Citation: Jin-li REN, Li ZHANG, Si-wei WANG, . Intervention effect and mechanism of oat β-glucan on diabetic nephropathy in rats[J]. Chinese Journal of Public Health, 2018, 34(6): 819-822. DOI: 10.11847/zgggws1117131

燕麦β-葡聚糖对糖尿病大鼠肾病干预作用及机制

Intervention effect and mechanism of oat β-glucan on diabetic nephropathy in rats

  • 摘要:
      目的  探讨燕麦β–葡聚糖对糖尿病大鼠肾病进展的干预作用及机制。
      方法  采用链脲佐菌素(65 mg/kg)一次性腹腔注射 + 单侧肾切除的方式构建糖尿病肾病大鼠模型,造模成功后随机分为4组,分别为模型组(蒸馏水),和低、中、高剂量燕麦β–葡聚糖组(0.275、0.550、1.100 g/kg),每组12只;同时另取10只大鼠行假手术并灌胃蒸馏水,为对照组;干预8周。采集血液和尿液,检测尿素氮(BUN)、尿酸(UA)、血肌酐(CR)和血清炎症因子白细胞介素–6(IL-6)、血管内皮生长因子(VEGF)水平,并取肾脏做病理组织检测。
      结果  与对照组比较,模型组大鼠血清尿素氮、VEGF、IL-6水平分别为(14.80 ± 3.63)mmol/L、(312.54 ± 13.39)、(145.96 ± 5.67)ng/L明显升高(P < 0.05);与模型组比较,燕麦β–葡聚糖0.275 g/kg组大鼠血清尿素氮水平(10.39 ± 2.04)mmol/L明显下降,燕麦β–葡聚糖0.550 g/kg组大鼠血清VEGF及IL-6水平分别为(269.94 ± 16.70)、(129.71 ± 6.48)ng/L明显下降,差异有统计学意义(P < 0.05);与模型组比较,燕麦β–葡聚糖组大鼠肾脏组织结构损伤明显减轻。
      结论  燕麦β–葡聚糖可有效改善糖尿病肾病大鼠肾功能,延缓肾脏组织结构损伤,其机制可能与下调炎症相关因子表达水平,改善机体炎症状态有关。

     

    Abstract:
      Objective  To explore intervention effect and mechanism of oat β-glucan (OG) on diabetic nephropathy (DN) in rats.
      Methods  Sprague-Dawley (SD) rat DN model was established with peritoneal injection of streptozotocin(65 mg/kg·bw) plus unilateral nephrectomy. Then the model rats were divided in to 4 groups (12 in each group) : a DN model group gavaged with distilled water and three OG groups gavaged with OG at dosages of 0.275, 0.55, and 1.1 g/kg.bw once a day for 8 consecutive weeks. Another 10 normal control rats were treated with distilled water and sham operation. By the end of the experiment, blood urea nitrogen (BUN) , uric acid (UA) , and creatinine (CR) and serum vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6) were measured; pathological changes of kidneys were also observed.
      Results  The BUN (14.80 ± 3.63 mmol/L), VEGF (312.54 ± 13.39 ng/L), and IL-6 (145.96 ± 5.67 ng/L) of the DN model rats were significantly higher than those of the normal control rats (P < 0.05 for all). Compared with those of the DN model rats, the BUN (10.39 ± 2.04 mmol/L) of the DN rats treated with 0.275 g/kg.bw OG decreased significantly; the VEGF (269.94 ± 16.70 ng/L) and IL-6 (129.71 ± 6.48 ng/L) of the DN rats treated with 0.550 g/kg.bw OG were reduced significantly (both P < 0.05). In addition, alleviated structure damage of kidney tissues were observed in all the DN rats treated with OG in contrast to the DN model rats.
      Conclusion  Oat β-glucan could effectively improve renal function and attenuate damages of kidney tissue by down-regulating inflammation-related factors in rats with diabetic nephropathy.

     

/

返回文章
返回